524414 — Norris Medicines Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹135.41m
- IN₹350.55m
- IN₹81.32m
Annual cashflow statement for Norris Medicines, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -32.6 | -17.5 | -11.9 | -12.4 | -2.81 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -0.116 | -0.119 | 0.103 | -0.185 | -0.2 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 5.3 | 17.7 | 6.86 | 11.7 | 3.87 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -10.1 | 12 | 1.7 | 5.1 | 5.78 |
| Capital Expenditures | -0.554 | -0.298 | -0.011 | -0.19 | -0.096 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.335 | 0.08 | 0.519 | 0.151 | -0.71 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.889 | -0.218 | 0.507 | -0.039 | -0.806 |
| Financing Cash Flow Items | -14.8 | -15 | -3.7 | -4.4 | -5 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 11 | -11.8 | -2.03 | -5.04 | -5.15 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.021 | 0.017 | 0.172 | 0.022 | -0.182 |